Kimberly C. Wiegand

发表

Mutation of FOXL2 in granulosa-cell tumors of the ovary.

Ryan D. Morin, A. deFazio, D. Bowtell, 2009, The New England journal of medicine.

ARID1A mutations in endometriosis-associated ovarian carcinomas.

Richard A. Moore, S. Fereday, D. Bowtell, 2010, The New England journal of medicine.

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

Fan Zhang, Yiling Lu, Gordon B Mills, 2014, BMC Cancer.

Reversion to virulence and efficacy of an attenuated Canarypox vaccine in Hawai'i 'Amakihi (Hemignathus virens).

C. Atkinson, D. Triglia, Kimberly C. Wiegand, 2012, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

REVERSION TO VIRULENCE AND EFFICACY OF AN ATTENUATED CANARYPOX VACCINE IN HAWAI‘I ‘AMAKIHI (HEMIGNATHUS VIRENS)

C. Atkinson, D. Triglia, Kimberly C. Wiegand, 2012 .

Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

S. Shah, D. Huntsman, J. Senz, 2013, PloS one.

G. Mills, S. Leung, D. Huntsman, 2014, BMC Cancer.

The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.

D. Huntsman, Kimberly C. Wiegand, C. Chow, 2013, The American journal of pathology.

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

S. Shah, D. Huntsman, J. Senz, 2013, PloS one.

ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts.

C. Streutker, D. Huntsman, B. Clarke, 2014, Human pathology.

Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas

S. Wiseman, R. Gascoyne, C. Steidl, 2011, The Journal of pathology.

Inflammation-Induced Metastatic Colonization of the Lung Is Facilitated by Hepatocyte Growth Factor-Secreting Monocyte-Derived Macrophages

Kimberly C. Wiegand, M. Gold, C. Roskelley, 2021, Molecular Cancer Research.

Clear cell ovarian carcinoma and emergence of the novel tumour suppressor gene ARID1A

Kimberly C. Wiegand, 2013 .

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Anna Adamiak, Russell Vang, C Blake Gilks, 2009, BMC Cancer.

Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

S. Shah, D. Huntsman, J. Senz, 2013, PLoS ONE.

Use of mutation profiles to refine the classification of endometrial carcinomas

Thomas Zeng, Martin Hirst, Kane Tse, 2012, The Journal of pathology.

Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles

S. Shah, Jiarui Ding, D. Huntsman, 2014, Modern Pathology.

Inflammation-Induced Metastatic Colonization of the Lung Is Facilitated by Hepatocyte Growth Factor-Secreting Monocyte-Derived Macrophages

Kimberly C. Wiegand, M. Gold, C. Roskelley, 2021, Molecular Cancer Research.

ARID1A mutations in endometriosis-associated ovarian carcinomas.

Richard A. Moore, Allen D. Delaney, S. Fereday, 2010, The New England journal of medicine.